Answers are grounded in this paper and cite their sources.
The review summarizes and systematizes data on the anti-inflammatory effect of the synthetic peptide LKEKK in vitro and in vivo. Based on the analysis, it was concluded that this peptide has a significant therapeutic potential as an anti-inflammatory drug in Crohn’s disease, various forms of colitis and contact dermatitis.
No takes yet. Share an insight, caveat, or question.
Navolotskaya et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: